In addition, downregulation of the TGF-β1 gene might be used as a potential biomarker for early CVD risk assessment in adolescents with T1D, due to its independent significant negative association with urinary albumin excretion rate. The gene discussed is TGFB1; the disease is type 1 diabetes mellitus.